IRCT20251127068128N2 IRCT 2026-01-30 Ahvaz University of Medical Sciences The effect of melatonin on sleep quality and anxiety in hemodialysis patients. Studying the effect of melatonin on sleep quality and anxiety in hemodialysis patients 2026-02-04 anticipated 56 Complete https://irct.ir/trial/88791 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: After meeting the inclusion and exclusion criteria, eligible patients are randomly assigned to two groups: intervention (receiving melatonin) and control (without drug intervention) in a 1:1 ratio using a simple random number table. 3 Condition 1: End-stage chronic renal failure treated with hemodialysis. Condition 2: Sleep quality disorders in hemodialysis patients. Condition 3: Sleep quality disorders in hemodialysis patients. Intervention 1: Intervention group: The patients in this group include 28 people who take 3 mg of melatonin every night 30 minutes before bedtime. The treatment period is 6 weeks and the aim of this intervention is to examine the effects of melatonin on sleep quality in hemodialysis patients. Intervention 2: Control group: The patients in this group, which consists of 28 people, will not receive any drug intervention. This group is intended to examine the effect of melatonin compared to the natural sleep and anxiety patterns of hemodialysis patients.Initially, patients will be given a sleep disorder and anxiety disorder questionnaire. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is Still undecided - no release schedule yet